Rayner doubles IOL manufacturing capacity to meet growing demand
Posted on 2/04/2025
02 April 2025 | In response to demand growth, Rayner – a global leader in solutions for cataract surgery – has completed an extensive expansion of its Worthing (UK) production facility, doubling the number of intraocular lenses (IOLs) it can manufacture annually to 4 million.
Since opening its purpose-built manufacturing facility in 2017, every Rayner IOL has been produced in Worthing – including over six million RayOne fully preloaded systems. The RayOne family features the pioneering EMV lens platform, and now the Galaxy and Galaxy Toric, Rayner’s fastest-growing lenses since the world’s first IOL back in 1949.
Playing a lead role in the futureproofing of Rayner’s facility, Tom Heron, Head of Manufacturing, said ““We are thrilled to have completed our latest factory expansion. This development enables us to uphold our rigorous quality control standards as we continue to grow—including four meticulous inspections of every single IOL. Combined with the opening of our new global warehouse near Gatwick Airport in 2024, this expansion reinforces our commitment to an uninterrupted supply for customers worldwide.”
David Forsythe, Rayner Chief Operating Officer, commented “Our teams have worked incredibly hard to bring this ambitious expansion to life, which included the installation of an additional autoclave, automation and investing in new energy efficient plant equipment. I would like to thank everyone involved for their efforts. As the only British manufacturer of IOLs, we take immense pride in our precise and increasingly sustainable lens production process—and in regularly welcoming surgeons to witness it firsthand.”
Watch our factory tour with Head of Manufacturing, Tom Heron:
About Rayner:
Since the implantation of the first Rayner intraocular lens by Sir Harold Ridley in 1949, Rayner has had the goal to improve vision and restore sight worldwide. Today, Rayner’s mission remains to deliver innovative and clinically superior ophthalmic products that respond to the expectations of our global customers to improve the sight and quality of life of their patients.
Headquartered in the United Kingdom, Rayner markets its medical devices, pharmaceuticals, and digital solutions worldwide in over 80 countries through a network of distributors and includes direct sales teams in the United Kingdom, Eire, USA, Canada, Brazil, India, Poland, Australia, Germany, Austria, Switzerland, France, Italy, Spain, and Portugal.
Not all Rayner products are approved for sale in every country. Please contact your local Rayner distributor for details of which products are available in your area.
©2025 Rayner Group, all rights reserved. ‘Rayner’, ‘RayOne’, ‘EMV’ and ‘Galaxy’ are proprietary marks of the Rayner Group. All other trademarks are property of their respective owners.
Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ | EC 2025-50 EN